Parkinson's disease (PD) is the second most common neurodegenerative disorder, primarily characterized by motor dysfunction.

The US Environmental Protection Agency (EPA) has long maintained that the herbicide is safe for use under strict ...

Research spanning more than 20 years has led the UPV/EHU's Neurochemistry and Neurodegeneration group under Dr. Rafael Rodríguez-Puertas to discover a promising avenue for the development of new ...

Ketamine disrupts abnormal brain activity, offering long-term relief for Parkinson’s dyskinesia in early clinical trials.

This insightful interactive webinar delves into the motor and non-motor symptoms experienced by patients with Parkinson’s ...